543500 EVOQ

Evoq Remedies Share PriceEvoq Remedies

₹12.1
As on 08 December, 2023 | 21:52 BSE: 543500 NSE: EVOQISIN: INE0JVD01011

Evoq Remedies Performance

Day Range

  • Low
  • High
₹ 12.1

52 Week Range

  • Low
  • High
₹ 12.1
  • Open Price
  • Previous Close
  • Volume

Start SIP in Evoq Remedies

Start SIP

Evoq Remedies Share Price

  • Over 1 Month -6.92%
  • Over 3 Month -19.87%
  • Over 6 Month -8.68%
  • Over 1 Year -25.77%

Evoq Remedies Key Statistics

Evoq Remedies Investment Rating

  • Master Rating:
  • Evoq Remedies has an operating revenue of Rs. 56.27 Cr. on a trailing 12-month basis. An annual revenue growth of 57% is outstanding, Pre-tax margin of 11% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 136 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Evoq Remedies Financials
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2617
Operating Expenses Annual Cr 2415
Operating Profit Annual in Cr -41
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 10
Net Profit Annual Cr 21
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -28-28
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr 2929
Net Cash Flow Annual Cr 2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 2523
Fixed Assets Annual Cr 00
Total Non Current Assets Annual Cr 00
Total Current Assets Annual Cr 3533
Total Assets Annual Cr 3533
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 1817
ROE Annual % 75
ROCE Annual % 96
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 119
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Evoq Remedies Technicals

EMA & SMA

Current Price
₹12.1
0 (0%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹12.50
  • 50 Day
  • ₹13.17
  • 100 Day
  • ₹13.65
  • 200 Day
  • ₹14.07
  • 20 Day
  • ₹12.45
  • 50 Day
  • ₹13.57
  • 100 Day
  • ₹14.02
  • 200 Day
  • ₹14.10

Evoq Remedies Resistance and Support

PIVOT
₹12.1
Resistance
First Resistance 12.10
Second Resistance 12.10
Third Resistance 12.10
RSI 43.14
MFI 40.59
MACD Single Line -0.41
MACD -0.38
Support
First Resistance 12.10
Second Resistance 12.10
Third Resistance 12.10

Evoq Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,000 400,000 100
Week 12,800 1,120,000 87.5
1 Month 12,211 1,031,545 84.48
6 Month 11,904 1,017,554 85.48

Evoq Remedies Result Highlights

Evoq Remedies Synopsis

BSE-Medical-Ethical Drugs

Evoq Remedies belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 20.39 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2023. Evoq Remedies Ltd. is a Public Limited Listed company incorporated on 24/02/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC059692 and registration number is 059692.
Market Cap 16
Sales 20
Shares in Float 0.35
No of funds
Yield
Book Value 0.66
U/D Vol ratio 0.5
LTDebt / Equity
Alpha -0.02
Beta 1.41

Evoq Remedies

Owner NameSep-23Mar-23
Promoters 73.53%73.53%
Individual Investors 24.91%25.21%
Others 1.56%1.26%

Evoq Remedies Management

Name Designation
Mr. Bhumishth Narendrabhai Patel Chairman & Managing Director
Mrs. Payal Bhumishth Patel Non Exe.Non Ind.Director
Mr. Tarunkumar Gunvantlal Patel Non Exe.Non Ind.Director
Mr. Pranav Manoj Vajani Independent Director
Mr. Digesh Mansukhlal Deshaval Independent Director

Evoq Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Evoq Remedies Corporate Action

Date Purpose Remarks
2023-11-10 Half Yearly Results (Revised)
2023-05-25 Audited Results
2022-11-07 Half Yearly Results & Rights issue
2022-05-30 Audited Results

Evoq Remedies FAQs

What is Share Price of Evoq Remedies ?

Evoq Remedies share price is ₹12 As on 08 December, 2023 | 21:38

What is the Market Cap of Evoq Remedies ?

The Market Cap of Evoq Remedies is ₹16.5 Cr As on 08 December, 2023 | 21:38

What is the P/E ratio of Evoq Remedies ?

The P/E ratio of Evoq Remedies is As on 08 December, 2023 | 21:38

What is the PB ratio of Evoq Remedies ?

The PB ratio of Evoq Remedies is 0.7 As on 08 December, 2023 | 21:38

Q2FY23